Acarbose Hydrate is a complex oligosaccharide that competitively inhibits intestinal alpha-glucosidase enzymes, slowing carbohydrate breakdown and blunting postprandial glucose excursions in type 2 diabetes. Its large, multi-component structure makes impurity and related-substance characterisation analytically demanding. Simson Pharma's Acarbose Hydrate reference standard and impurity set support this complex but clinically important QC workload.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Acarbose Hydrate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.